SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ChemTrak
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeff Wou who wrote (15)10/11/1996 10:52:00 AM
From: William Presti   of 48
 
The upward potential for CMTR is certainly there.
If you take together existing products and marketing relationships both domestic and international, one would expect favorable earnings growth for this company. On top of that you have the pending approval of the HIV test kit (which will apparently we will hear about within the next 60 days or so), and other products the company indicates are under development. AND, consider the market potential for these home diagnostic kits. I personnaly would expect to see CMTR back over 4 dollars by year's end. That could be a conservative guess. Guess is the operative word here. As with any stock investment, you can have all the greatest of potential, but unless it is widely recognized the stock will remain undervalued. Future FDA approvals and product introductions and hopefully favorable quarterly reports will draw attention to CMTR. We'll see. BTW, I have tried unsucessfully on two occasions to get through to CMTR's investor relations representative. Anybody have better luck?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News